GMRE
Income statement / Annual
Last year (2023), Global Medical REIT Inc.'s total revenue was $156.65 M,
an increase of 14.11% from the previous year.
In 2023, Global Medical REIT Inc.'s net income was $20.61 M.
See Global Medical REIT Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
08/31/2014 |
Operating Revenue |
$156.65 M
|
$137.28 M
|
$115.94 M
|
$93.73 M
|
$70.73 M
|
$53.19 M
|
$30.22 M
|
$8.08 M
|
$2.06 M
|
$380,405.00
|
Cost of Revenue |
$86.22 M |
$25.19 M |
$15.49 M |
$10.87 M |
$5.96 M |
$3.72 M |
$1.86 M |
$1.43 M |
$1.02 M |
$360,000.00 |
Gross Profit |
$70.44 M |
$112.10 M |
$100.45 M |
$82.86 M |
$64.77 M |
$49.47 M |
$28.36 M |
$6.65 M |
$1.04 M |
$20,405.00 |
Gross Profit Ratio |
0.45 |
0.82 |
0.87 |
0.88 |
0.92 |
0.93 |
0.94 |
0.82 |
0.51 |
0.05 |
Research and Development
Expenses |
$0.00
|
$0.15
|
$0.17
|
-$0.03
|
$0.14
|
$0.27
|
-$0.00
|
-$0.77
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$16.85 M
|
$16.55 M
|
$16.45 M
|
$29.96 M
|
$12.80 M
|
$9.96 M
|
$8.61 M
|
$5.73 M
|
$865,141.00
|
$604,866.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$16.85 M
|
$16.55 M
|
$16.45 M
|
$29.96 M
|
$12.80 M
|
$9.96 M
|
$8.61 M
|
$5.73 M
|
$865,141.00
|
$604,866.00
|
Other Expenses |
$0.00 |
$56.72 M |
$46.88 M |
$36.35 M |
$24.64 M |
$17.27 M |
$121,000.00 |
$130,775.00 |
$659,671.00 |
$129,081.00 |
Operating Expenses |
$16.90 M |
$73.27 M |
$63.33 M |
$66.32 M |
$37.44 M |
$27.23 M |
$18.61 M |
$8.10 M |
$1.52 M |
$733,947.00 |
Cost And Expenses |
$103.11 M |
$98.46 M |
$78.82 M |
$77.18 M |
$43.40 M |
$30.95 M |
$20.47 M |
$8.10 M |
$1.52 M |
$733,947.00 |
Interest Income |
$0.00 |
$25.23 M |
$19.70 M |
$18.68 M |
$17.47 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$30.89 M |
$25.23 M |
$19.70 M |
$18.68 M |
$17.47 M |
$14.98 M |
$7.44 M |
$4.14 M |
$1.52 M |
$298,664.00 |
Depreciation &
Amortization |
$58.14 M
|
$98.81 M
|
$78.97 M
|
$77.51 M
|
$43.70 M
|
$31.33 M
|
$23.00 M
|
$10.43 M
|
$659,671.00
|
$129,081.00
|
EBITDA |
$111.68 M
|
$96.49 M
|
$84.00 M
|
$53.00 M
|
$50.82 M
|
$40.20 M
|
$17.35 M
|
$2.48 M
|
$569,526.00
|
-$224,461.00
|
EBITDA Ratio |
0.71 |
0.7 |
0.72 |
0.56 |
0.73 |
0.76 |
0.66 |
0.31 |
0.58 |
-0.59 |
Operating Income Ratio
|
0.24
|
0.28
|
0.32
|
0.18
|
0.39
|
0.42
|
0.24
|
-0.27
|
-0.74
|
-1.71
|
Total Other
Income/Expenses Net |
-$16.20 M
|
-$18.83 M
|
-$18.78 M
|
-$30.77 M
|
-$17.47 M
|
-$7.68 M
|
-$9.96 M
|
-$6.33 M
|
-$2.13 M
|
$0.00
|
Income Before Tax |
$21.73 M |
$20.00 M |
$18.34 M |
-$2.50 M |
$9.59 M |
$14.56 M |
-$87,000.00 |
-$6.35 M |
-$1.61 M |
-$652,206.00 |
Income Before Tax Ratio
|
0.14
|
0.15
|
0.16
|
-0.03
|
0.14
|
0.27
|
-0
|
-0.79
|
-0.78
|
-1.71
|
Income Tax Expense |
$0.00 |
$25.23 M |
$20.42 M |
$18.11 M |
$17.83 M |
$1.07 M |
-$49,000.00 |
$4.27 M |
$1.52 M |
$597,328.00 |
Net Income |
$20.61 M |
-$5.23 M |
-$2.07 M |
-$20.61 M |
-$8.24 M |
$13.49 M |
-$38,000.00 |
-$6.35 M |
-$1.61 M |
-$652,206.00 |
Net Income Ratio |
0.13 |
-0.04 |
-0.02 |
-0.22 |
-0.12 |
0.25 |
-0 |
-0.79 |
-0.78 |
-1.71 |
EPS |
0.23 |
-0.08 |
-0.0342 |
-0.45 |
-0.24 |
0.61 |
-0.0019 |
-0.68 |
-6.44 |
-13.49 |
EPS Diluted |
0.23 |
-0.08 |
-0.0342 |
-0.45 |
-0.24 |
0.61 |
-0.0019 |
-0.68 |
-6.44 |
-13.49 |
Weighted Average Shares
Out |
$65.55 M
|
$65.46 M
|
$60.64 M
|
$46.26 M
|
$33.87 M
|
$21.97 M
|
$19.62 M
|
$9.30 M
|
$250,000.00
|
$48,356.00
|
Weighted Average Shares
Out Diluted |
$65.55 M
|
$65.46 M
|
$60.64 M
|
$46.26 M
|
$33.87 M
|
$21.97 M
|
$19.62 M
|
$9.30 M
|
$250,000.00
|
$48,356.00
|
Link |
|
|
|
|
|
|
|
|
|
|